AbSci
The global leader in cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry. Learn more
Launch date
Employees
Market cap
CAD604m
Enterprise valuation
CAD424m (Public information from Sep 2024)
Share price
$3.98 ABSI
Vancouver Washington (HQ)
Authorizing premium user...